USPTO serial 86856768
Serial No. 86856768
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, CYNTHIA RINALDI
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 86856768?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael D. Schumann
MICHAEL D. SCHUMANN HAMRE SCHUMANN MUELLER & LARSON P C45 S 17TH ST STE 2700MINNEAPOLIS, MN 55402-0902UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for prevention and treatment of disorders of the nervous system, namely, tonics; medicines for the treatment of immune system-related diseases and disorders, namely, tonics; medicines for the treatment of cardiovascular system-related diseases and disorders, namely, tonics; medicines for the treatment of metabolic system-related diseases and disorders, namely, tonics; medicines for the treatment of respiratory system-related diseases and disorders, namely, tonics; medicines for the treatment of musculoskeletal system-related diseases and disorders, namely, tonics; medicines for the treatment of genitourinary system-related diseases and disorders, namely, tonics; medicines for the treatment of skin-related diseases and disorders, namely, tonics; medicines for the treatment of oncological-related diseases and disorders, namely, tonics; medicines for the treatment of blood disorders, namely, tonics; medicines for the treatment of eye diseases, namely, tonics; medicinal drinks; dietetic foods adapted for medical purposes; nutritional supplements; medicinal herbs; prepared Chinese medicine for the treatment of immune system-related diseases and disorders; prepared Chinese medicine for the treatment of cardiovascular system-related diseases and disorders; prepared Chinese medicine for the treatment of metabolic system-related diseases and disorders; prepared Chinese medicine for the treatment of respiratory system-related diseases and disorders; prepared Chinese medicine for the treatment of musculoskeletal system-related diseases and disorders; prepared Chinese medicine for the treatment of genitourinary system-related diseases and disorders; prepared Chinese medicine for the treatment of skin-related diseases; prepared Chinese medicine for the treatment of oncological-related diseases; prepared Chinese medicine for the treatment of blood disorders; prepared Chinese medicine for the treatment of eye diseases; prepared Chinese medicine for the treatment of inflammatory disorders; prepared Chinese medicine for use in gastroenterological disorders; decoctions for pharmaceutical purposes, namely, for the prevention and treatment of disorders of the nervous system; decoctions for pharmaceutical purposes, namely, for the treatment of immune system-related diseases and disorders; decoctions for pharmaceutical purposes, namely, for the treatment of cardiovascular-related diseases and disorders; decoctions for pharmaceutical purposes, namely, for the treatment of metabolic system-related diseases and disorders; decoctions for pharmaceutical purposes, namely, for the treatment of respiratory system-related diseases and disorders; decoctions for pharmaceutical purposes, namely, for the treatment of musculoskeletal system-related diseases and disorders; decoctions for pharmaceutical purposes, namely, for the treatment of genitourinary system-related diseases and disorders; decoctions for pharmaceutical purposes, namely, for the treatment of inflammatory disorders; decoctions for pharmaceutical purposes, namely, for the treatment of skin-related diseases; decoctions for pharmaceutical purposes, namely, for the treatment of oncological-related diseases; decoctions for pharmaceutical purposes, namely, for the treatment of blood disorders; decoctions for pharmaceutical purposes, namely, for the treatment of eye diseases; decoctions for pharmaceutical purposes, namely, for the treatment of gastroenterological disorders; drugs for medical purposes, namely, for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, ocular, reproductive, circulatory, digestive, ear, blood, digestive, ear, blood, psychiatric, behavioral, nervous, and immune system-related diseases and disorders; medicinal roots; ginseng for medicinal use; medicinal preparations for the mouth to be applied in the form of compressed tablets for prevention and treatment of disorders of the nervous system; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of immune system-related diseases and disorders; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of cardiovascular system-related diseases and disorders; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of metabolic system-related diseases and disorders; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of respiratory system-related diseases and disorders; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of musculoskeletal system-related diseases and disorders; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of genitourinary system-related diseases and disorders; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of skin-related diseases; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of oncological-related diseases; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of blood disorders; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of eye diseases; medicinal preparations for the mouth to be applied in the form of compressed tablets for the treatment of inflammatory disorders; medicinal preparations for the mouth to be applied in the form of compressed tablets for use in gastroenterological disorders; medicines for human purposes for prevention and treatment of disorders of the nervous system; medicines for human purposes for the treatment of cancer, dermal diseases, heart diseases, respiratory diseases and disorders, infectious diseases, bone diseases, circulatory disease, cerebral disease, and articular rheumatism; medicines for human purposes for the treatment of inflammatory disorders; medicines for human purposes for use in gastroenterological disorders; raw material medicines for the treatment of nervous system diseases, immune system diseases, cardiovascular system diseases, metabolic system diseases, respiratory system diseases, digestive system diseases, circulatory system diseases, urinary system diseases, endocrine system diseases, blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Chinese medicine bag, namely, kits and bags comprised of medicinal herbs in dried or preserved form | ACTIVE | — |
| 029 | Milk products excluding ice cream, ice milk and frozen yogurt; fatty substances for the manufacture of edible fats, namely, oils and fats for food; lecithin for culinary purposes; seaweed extracts for food; fruit, preserved; vegetables, preserved; prepared nuts; dried edible mushroom; tinned fruits; pollen prepared as foodstuff | ACTIVE | — |
| 030 | Cocoa; tea; loquat syrup for flavoring food; oat-based food, namely, rolled oats; cereal-based snack food; rice-based snack food; cereal preparations, namely, processed cereals; sugar; gluten prepared as foodstuff, namely, gluten additives for culinary purposes; seasonings | ACTIVE | — |
| 031 | Fresh wheat; unprocessed grains; poultry, live; live animals; fresh nuts; fruit, fresh; vegetables, fresh; seeds for planting; animal foodstuffs; live plants | ACTIVE | — |
| 035 | Advertising; commercial administration of the licensing of the goods and services of others; sales promotion for others; import-export agency services; personnel management consultancy; business auditing; rental of sales stands; rental of vending machines; sponsorship search; retail store services and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies | ACTIVE | — |
| 040 | Processing of medicinal materials, namely, custom manufacturing of pharmaceuticals, anti-allergic drugs, and prescription and non-prescription medicines for the prevention and treatment of dermatological, bacterial, and gynecological diseases by pharmaceutical compounders; grinding; processing and handling of chemical reagents, namely, manufacturing chemical reagents for others; food and drink preservation, namely, freezing of food and drink for others; printing; decontamination of hazardous materials; air purification; water treating; tea processing; stripping finishes, namely, metal finishing services for others | ACTIVE | — |
| 044 | Pharmaceutical advice; plant nursery services; sanatorium services; dietary and nutritional guidance; massage; rental of sanitation facilities; health counselling; pharmacists' services to make up prescriptions; health care; physiotherapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LKK HEALTH PRODUCTS GROUP LIMITED
- Other trademarks owned by LKK HEALTH PRODUCTS GROUP LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 030
- Other trademarks in Class 031
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 044
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 24, 2018 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 24, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 22, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 27, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 27, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 20, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 7, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2018 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jan 17, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jan 17, 2018 | PGRR | PETITION GRANTED - RESPONSE RECEIVED | — |
| Jan 10, 2018 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 4, 2017 | ISPO | WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST | — |
| Dec 1, 2017 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Dec 1, 2017 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Nov 21, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 21, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 1, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 1, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 1, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 1, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 17, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 17, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 17, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 27, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 27, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jan 9, 2017 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jan 9, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 9, 2017 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jan 9, 2017 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Nov 9, 2016 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 9, 2016 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 7, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 7, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 13, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 5, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 4, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 28, 2015 | NWAP | NEW APPLICATION ENTERED | — |